The association of pericytes (PCs) to newly formed blood vessels has been suggested to regulate endothelial cell (EC) proliferation, survival, migration, differentiation, and vascular branching. Here, we addressed these issues using PDGF-B– and PDGF receptor-β (PDGFR-β)–deficient mice as in vivo models of brain angiogenesis in the absence of PCs. Quantitative morphological analysis showed that these mutants have normal microvessel density, length, and number of branch points. However, absence of PCs correlates with endothelial hyperplasia, increased capillary diameter, abnormal EC shape and ultrastructure, changed cellular distribution of certain junctional proteins, and morphological signs of increased transendothelial permeability. Brain endothelial hyperplasia was observed already at embryonic day (E) 11.5 and persisted throughout development. From E 13.5, vascular endothelial growth factor-A (VEGF-A) and other genes responsive to metabolic stress became upregulated, suggesting that the abnormal microvessel architecture has systemic metabolic consequences. VEGF-A upregulation correlated temporally with the occurrence of vascular abnormalities in the placenta and dilation of the heart. Thus, although PC deficiency appears to have direct effects on EC number before E 13.5, the subsequent increased VEGF-A levels may further abrogate microvessel architecture, promote vascular permeability, and contribute to formation of the edematous phenotype observed in late gestation PDGF-B and PDGFR-β knock out embryos.
Skip Nav Destination
Article navigation
30 April 2001
Article|
April 30 2001
Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis
Mats Hellström,
Mats Hellström
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Search for other works by this author on:
Holger Gerhardt,
Holger Gerhardt
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
cInstitute of Pathology, University of Tuebingen, 72076 Tuebingen, Germany
Search for other works by this author on:
Mattias Kalén,
Mattias Kalén
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
Search for other works by this author on:
Xuri Li,
Xuri Li
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Search for other works by this author on:
Ulf Eriksson,
Ulf Eriksson
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Search for other works by this author on:
Hartwig Wolburg,
Hartwig Wolburg
cInstitute of Pathology, University of Tuebingen, 72076 Tuebingen, Germany
Search for other works by this author on:
Christer Betsholtz
Christer Betsholtz
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
Search for other works by this author on:
Mats Hellström
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Holger Gerhardt
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
cInstitute of Pathology, University of Tuebingen, 72076 Tuebingen, Germany
Mattias Kalén
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
Xuri Li
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Ulf Eriksson
bLudwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, SE-171 77 Stockholm, Sweden
Hartwig Wolburg
cInstitute of Pathology, University of Tuebingen, 72076 Tuebingen, Germany
Christer Betsholtz
aDepartment of Medical Biochemistry, Göteborg University, SE-405 30 Göteborg, Sweden
Abbreviations used in this paper: E, embryonic day; EC, endothelial cell; Glut-1, glucose transporter 1; LDH, lactate dehydrogynase; PC, pericyte; PDGFR-β, PDGF receptor-β; PGK, phosphoglycerate kinase; VEGF-A, vascular endothelial growth factor-A; vSMC, vascular smooth muscle cell.
Received:
September 21 2000
Revision Requested:
January 26 2001
Accepted:
March 13 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 153 (3): 543–554.
Article history
Received:
September 21 2000
Revision Requested:
January 26 2001
Accepted:
March 13 2001
Citation
Mats Hellström, Holger Gerhardt, Mattias Kalén, Xuri Li, Ulf Eriksson, Hartwig Wolburg, Christer Betsholtz; Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis. J Cell Biol 30 April 2001; 153 (3): 543–554. doi: https://doi.org/10.1083/jcb.153.3.543
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement